deltatrials
Completed PHASE1/PHASE2 NCT00090402

Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease

Fish Oil and Alpha Lipoic Acid in Mild Alzheimer's Disease

Sponsor: National Center for Research Resources (NCRR)

Conditions Alzheimer's Disease Dementia Hyperlipidemia Inflammation Oxidative Stress
Interventions Fish Oil Fish Oil Placebo Lipoic Acid Lipoic Acid Placebo
Updated 6 times since 2017 Last updated: Jun 21, 2017 Started: Apr 30, 2004 Primary completion: Jan 3, 2006 Completion: Aug 31, 2007

This PHASE1/PHASE2 trial investigates Alzheimer's Disease and Dementia and is currently completed. National Center for Research Resources (NCRR) leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Aug 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Aug 2017 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Center for Research Resources (NCRR)
  • National Institute on Aging (NIA)
  • Oregon Health and Science University
Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Portland, United States